ARYx Therapeutics

closed

Pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

HQ location

Fremont, United States

Website

Launch date

1997

Employees

Market cap

Enterprise value

$238k

Share price

$0.00 ARYX

Get premium to view all results

Date	Investors	Amount	Round
Jul 2002	investor investor investor	€0.0	round
Jun 2004	investor investor investor investor investor investor investor investor investor investor	€0.0	round
Feb 2006	investor investor	€0.0	round
Nov 2007	N/A	€0.0	round
Nov 2008	investor investor investor	€0.0	round
Nov 2009	investor investor investor	€0.0	round
Aug 2010	Lighthouse Capital Partners	$6.3m	Debt
Total Funding		000k